Lineage Cell Therapeutics Inc LCTX Price Prediction & Forecast

Home

Stock

LCTX

Forecast

LCTX Stock Price Prediction

Lineage Cell Therapeutics Inc

$1.84

10.17%

$0.17

At close: Feb 10, 16:00:00 GMT-5

$1.84

Pre-market: Feb 11, 07:49:51 GMT-5

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$1.67

Open

$1.67

Day's Range

$1.65 - $1.9

52 week range

$0.37 - $2.09

Volume

2.7M

Avg.Volume

1.4M

EPS (TTM)

-0.18

Dividend yield

Market Cap

$423.8M

What is LCTX?

Lineage Cell Therapeutics, Inc. operates as a clinical-stage biotechnology company developing new cellular therapies for degenerative retinal diseases, neurological conditions associated with demyelination, and aiding the body in detecting and combating cancer. The company is headquartered in Carlsbad, California and currently employs 70 full-time employees. The Company’s programs are based on its cell-based technology platform and associated development and manufacturing capabilities. From this platform, it designs, develops, manufactures, and tests specialized human cells with anatomical and physiological functions. Its neuroscience focused pipeline includes OpRegen, a retinal pigment epithelial cell therapy in phase II a development, for the treatment of geographic atrophy secondary to age-related macular degeneration; OPC1, an oligodendrocyte progenitor cell therapy in phase I/II a development for the treatment of spinal cord injuries; ANP1, an auditory neuronal progenitor cell therapy for the potential treatment of auditory neuropathy; PNC1, a photoreceptor neural cell therapy for the potential treatment of vision loss due to photoreceptor dysfunction or damage; and RND1.



Features

AI Copilot for Stock & Crypto

Resources

Market

Utilizing our sophisticated predictive model, we anticipate notable price fluctuations for LCTX in the upcoming periods. Looking toward the future, our 2027 projection indicates an average price target of $4.25. The lowest target is $2.02 and the highest is $9.45. Empower your investment choices with our cutting-edge, data-driven analysis!

LCTX Stock Price Prediction Summary

Top Analyst Ratings for LCTX

Based on 13 analysts giving stock ratings to LCTX, updated on Sep 01, 2025

Buy

Strong buy

Buy

Hold

Sell

Strong sell

Leveraging in-depth analyst evaluations, we have synthesized key insights from expert assessments to present a positive outlook for LCTX. Analysts highlight solid fundamentals and favorable market sentiment, suggesting upside potential in the near term. Based on this thorough expert analysis, we maintain an optimistic view of this stock. Our conclusion: LCTX is a Buy candidate.

LCTX stock price ended at $1.84 on Wednesday, after rising 0.00%

On the latest trading day Feb 11, 2026, the stock price of LCTX rose by 0.00%, climbing from $1.67 to $1.84. During the session, the stock saw a volatility of 14.46%, with prices oscillating between a daily low of $1.66 and a high of $1.90. Notably, trading volume dropped by -- shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 2.7M shares were traded, equating to a market value of approximately $423.8M.

LCTX Technical Signals

Technical Signals Summary

Buy Signals 3

Neutral Signals 2

Sell Signals 2

Strong Sell

Sell

Neutral

Buy

Strong Buy

LCTX currently exhibits 3 buy signals and 2 sell signals. The stock has been in an uptrend since 12:00 AM, with a total price change of -- during this period. Overall, the technical indicators point to a Buy outlook for the mid-term.

Bullish/Bearish Signals for LCTX

Our algorithms analyze key indicators like moving averages, RSI, MACD, and trading volume to generate bullish and bearish signals for LCTX. These insights help you make informed investment decisions.

Lineage Cell Therapeutics Inc (LCTX) Price

LCTX Stock Price Chart